Psychiatry and Neurology, Neurology · New York, NY
NPI
1265636997
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
240 E 38th St Fl 13
New York, NY, 10016
Phone (646) 501-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
480 services
Medicare patients, 2024
191
Average age 63
Drug cost, 2024
$5.1M
3,498 prescriptions
Company payments, 2025
$772
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert W Charlson was code 99214 (office e&m - established), 252 times for 139 patients. In total Robert W Charlson billed 480 services in 13 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 252 | 139 | $78.87 | $20K |
| 99213 Office E&M - Established | Office | 136 | 72 | $62.43 | $8,490 |
| 99215 Office E&M - Established | Office | 27 | 24 | $124.49 | $3,361 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $151.27 | $1,664 |
By year: 2022 $33K for 448 services; 2023 $36K for 479 services; 2024 $39K for 480 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert W Charlson prescribed most often to Medicare patients was Gabapentin, with 263 prescriptions and refills. In total Robert W Charlson wrote 3,498 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 263 | 425 | 57 | $4,651 |
| Baclofen Generic | 204 | 370 | 48 | $4,791 |
| Clonazepam Generic | 177 | 185 | 31 | $1,485 |
| Dalfampridine Er Dalfampridine | 167 | 171 | 22 | $99K |
| Kesimpta Pen Ofatumumab | 133 | 139 | 15 | $1.2M |
| Escitalopram Oxalate Generic | 128 | 216 | 28 | $1,187 |
| Duloxetine Hcl Generic | 125 | 197 | 21 | $1,403 |
| Bupropion Xl Bupropion Hcl | 124 | 222 | 22 | $3,244 |
| Pregabalin Generic | 112 | 122 | 21 | $3,685 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 84 | 138 | 17 | $5,106 |
| Sertraline Hcl Generic | 80 | 112 | 17 | $408 |
| Tizanidine Hcl Generic | 80 | 108 | 21 | $1,101 |
| Modafinil Generic | 59 | 77 | Under 11 | $4,804 |
| Diazepam Generic | 57 | 57 | 16 | $214 |
| Tecfidera Dimethyl Fumarate | 56 | 64 | Under 11 | $522K |
Brand drugs: - claims; generic drugs: 2,822 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert W Charlson $772 ($772 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novartis Pharmaceuticals Corporation with $207.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.